Recently, insulin-like growth factor (IGF) and its binding protein (IGFBP) involve in cancer development, progression and anti-cancer drug resistance, thus IGF/IGFBP is an emerging target of cancer therapy [53, 54]. The gene discussed is IGF1; the disease is cancer.